Skip to main content
Top
Published in:

Open Access 01-12-2023 | Dyslipidemia | Research

Magnitude and associated factors of dyslipidemia among patients with severe mental illness in dire Dawa, Ethiopia: neglected public health concern

Authors: Dilnessa Fentie, Shegaye Yibabie

Published in: BMC Cardiovascular Disorders | Issue 1/2023

Login to get access

Abstract

Background

Lipid metabolism abnormalities are an emerging risk factor for cardiovascular diseases. Due to the nature of the condition and their unhealthy lifestyles, patients with mental illnesses have a doubled risk of morbidity and mortality from dyslipidemia compared to the general population. To our knowledge the magnitude of dyslipidemia in patients with mental illnesses in the eastern Ethiopia has not been reported in the literature to date. Therefore, the aim of the study was to assess and compare the magnitude of dyslipidemia and its predictors among patients with severe mental illnesses and non-mentally ill control patients.

Methods

Nighty six subjects with serious psychiatric disorders and nighty six matched non-psychiatric control subjects who had no history of psychiatric illness were underwent a lipid profile test in Dire Dawa referral hospital, Ethiopia. The mentally ill clients were 18 years of age and older with schizophrenia, major depression, and bipolar disorders. Exposed study subjects were matched to control by age and sex. The data were cleaned and analyzed using SPSS software. A binary logistic regression model was used to determine the factors related to the magnitude of dyslipidemia. Both the crude odds ratio and the adjusted odds ratio with a 95% confidence interval were estimated.

Results

The magnitude of dyslipidemia among mentally ill patients was significantly higher (63.54%) compared to non-exposed controls (31.9%) in the subjects studied. In multiple logistic regression, urban dwellers were six times (AOR = 6.14, 95% CI: 1.2, 16) more likely at risk of developing dyslipidemia compared to rural participants. Similarly, physically inactive participants were nearly two-times (AOR = 1.8, 95% CI: 1.1, 12.9) more likely to develop dyslipidemia compared to physically active study participants. Moreover, study participants who had raised body mass index were 2.1 times (AOR = 2.1, 95% CI: 1.17, 15.3) more likely having dyslipidemia than their counterparts.

Conclusions

This study revealed that the prevalence of dyslipidemia is higher among mentally ill patients compared to non-mentally ill control study participants. Place of residence, physical inactivity, and raised BMI were significantly associated with dyslipidemia. Therefore, intensive screening of patients for dyslipidemia and its components is necessary during follow-up.
Literature
1.
go back to reference Et.al ana T. Pathophysiology of Dyslipidemia in Modern Medicine and its correlation. J Sci Hea lthcare Res. 2019;4(1). Et.al ana T. Pathophysiology of Dyslipidemia in Modern Medicine and its correlation. J Sci Hea lthcare Res. 2019;4(1).
3.
go back to reference Prasuna PL, Sagar KJV, Sudhakar TP, Rao GP. A placebo controlled trial on add-on modafinil on the anti-psychotic treatment emergent hyperglycemia and hyperlipidemia. Indian J Psychol Med. 2014;36(2):158–63.CrossRefPubMedPubMedCentral Prasuna PL, Sagar KJV, Sudhakar TP, Rao GP. A placebo controlled trial on add-on modafinil on the anti-psychotic treatment emergent hyperglycemia and hyperlipidemia. Indian J Psychol Med. 2014;36(2):158–63.CrossRefPubMedPubMedCentral
4.
go back to reference Gardner-Sood P, Lally J, Smith S, Atakan Z, Ismail K, Greenwood KE, et al. Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial. Psychol Med. 2015;45(12):2619–29.CrossRefPubMedPubMedCentral Gardner-Sood P, Lally J, Smith S, Atakan Z, Ismail K, Greenwood KE, et al. Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial. Psychol Med. 2015;45(12):2619–29.CrossRefPubMedPubMedCentral
5.
go back to reference Abosi O, Lopes S, Schmitz S, Fiedorowicz JG. Cardiometabolic effects of psychotropic medications. Horm Mol Biol Clin Investig. 2018;36(1):1–15. Abosi O, Lopes S, Schmitz S, Fiedorowicz JG. Cardiometabolic effects of psychotropic medications. Horm Mol Biol Clin Investig. 2018;36(1):1–15.
6.
go back to reference Carliner H, Collins PY, Cabassa LJ, McNallen A, Joestl SS, Lewis-Fernández R. Prevalence of cardiovascular risk factors among racial and ethnic minorities with schizophrenia spectrum and bipolar disorders: a critical literature review. Compr Psychiatry. 2014;55(2):233–47.CrossRefPubMed Carliner H, Collins PY, Cabassa LJ, McNallen A, Joestl SS, Lewis-Fernández R. Prevalence of cardiovascular risk factors among racial and ethnic minorities with schizophrenia spectrum and bipolar disorders: a critical literature review. Compr Psychiatry. 2014;55(2):233–47.CrossRefPubMed
7.
go back to reference John S, Dharwadkar K, Motagi MV. Study on association between lipid profile values and psychiatric disorders. J Clin Diagnostic Res. 2014;8(12):WC04–6. John S, Dharwadkar K, Motagi MV. Study on association between lipid profile values and psychiatric disorders. J Clin Diagnostic Res. 2014;8(12):WC04–6.
8.
go back to reference Abosi O, Lopes S, Schmitz S, Fiedorowicz G, City I, City I, et al. Cardiometabolic Effects of psychotropic medications Oluchi. Horm Mol Biol Clin Investig. 2019;36(1):1–27. Abosi O, Lopes S, Schmitz S, Fiedorowicz G, City I, City I, et al. Cardiometabolic Effects of psychotropic medications Oluchi. Horm Mol Biol Clin Investig. 2019;36(1):1–27.
9.
go back to reference Olfson M. Hyperlipidemia following treatment with antipsychotic medications. Am J Psychiatry. 2006;163(10):1821.CrossRefPubMed Olfson M. Hyperlipidemia following treatment with antipsychotic medications. Am J Psychiatry. 2006;163(10):1821.CrossRefPubMed
10.
go back to reference Ko YK, Soh MA, Kang SH, Lee J, Il. The prevalence of metabolic syndrome in schizophrenic patients using antipsychotics. Clin Psychopharmacol Neurosci. 2013;11(2):80–8.CrossRefPubMedPubMedCentral Ko YK, Soh MA, Kang SH, Lee J, Il. The prevalence of metabolic syndrome in schizophrenic patients using antipsychotics. Clin Psychopharmacol Neurosci. 2013;11(2):80–8.CrossRefPubMedPubMedCentral
11.
go back to reference Vik-Mo AO, Birkenaes AB, Fernø J, Jonsdottir H, Andreassen OA, Steen VM. Increased expression of lipid biosynthesis genes in peripheral blood cells of olanzapine-treated patients. Int J Neuropsychopharmacol. 2008;11(5):679–84.CrossRefPubMed Vik-Mo AO, Birkenaes AB, Fernø J, Jonsdottir H, Andreassen OA, Steen VM. Increased expression of lipid biosynthesis genes in peripheral blood cells of olanzapine-treated patients. Int J Neuropsychopharmacol. 2008;11(5):679–84.CrossRefPubMed
12.
13.
go back to reference Al-Hassan YT, Fabella EL, Estrella E, Aatif M. Prevalence and determinants of Dyslipidemia: data from a Saudi University Clinic. Open Public Health J. 2018;11(1):416–24.CrossRef Al-Hassan YT, Fabella EL, Estrella E, Aatif M. Prevalence and determinants of Dyslipidemia: data from a Saudi University Clinic. Open Public Health J. 2018;11(1):416–24.CrossRef
14.
go back to reference Gehani AA, Al-Hinai AT, Zubaid M, Almahmeed W, Hasani MRM, Yusufali AH, et al. Association of risk factors with acute myocardial infarction in Middle Eastern countries: the INTERHEART Middle East study. Eur J Prev Cardiol. 2014;21(4):400–10.CrossRefPubMed Gehani AA, Al-Hinai AT, Zubaid M, Almahmeed W, Hasani MRM, Yusufali AH, et al. Association of risk factors with acute myocardial infarction in Middle Eastern countries: the INTERHEART Middle East study. Eur J Prev Cardiol. 2014;21(4):400–10.CrossRefPubMed
15.
go back to reference Noubiap JJ, Bigna JJ, Nansseu JR, Nyaga UF, Balti EV, Echouffo-Tcheugui JB, et al. Prevalence of dyslipidaemia among adults in Africa: a systematic review and meta-analysis. Lancet Glob Heal. 2018;6(9):e998–1007.CrossRef Noubiap JJ, Bigna JJ, Nansseu JR, Nyaga UF, Balti EV, Echouffo-Tcheugui JB, et al. Prevalence of dyslipidaemia among adults in Africa: a systematic review and meta-analysis. Lancet Glob Heal. 2018;6(9):e998–1007.CrossRef
16.
go back to reference Hirigo AT, Teshome T, Abera Gitore W, Worku E. Prevalence and Associated factors of Dyslipidemia among Psychiatric patients on antipsychotic treatment at Hawassa University Comprehensive Specialized Hospital. Nutr Metab Insights. 2021;14. Hirigo AT, Teshome T, Abera Gitore W, Worku E. Prevalence and Associated factors of Dyslipidemia among Psychiatric patients on antipsychotic treatment at Hawassa University Comprehensive Specialized Hospital. Nutr Metab Insights. 2021;14.
17.
go back to reference Haile K, Timerga A. Dyslipidemia and its associated risk factors among adult type-2 diabetic patients at jimma university medical center, Jimma, Southwest Ethiopia. Diabetes Metab Syndr Obes Targets Ther. 2020;13:4589–97.CrossRef Haile K, Timerga A. Dyslipidemia and its associated risk factors among adult type-2 diabetic patients at jimma university medical center, Jimma, Southwest Ethiopia. Diabetes Metab Syndr Obes Targets Ther. 2020;13:4589–97.CrossRef
19.
go back to reference Kebede WM, Gizachew KD, Mulu GB. Prevalence and risk factors of Dyslipidemia among type 2 diabetes patients at a Referral Hospital, North Eastern Ethiopia. Ethiop J Health Sci. 2021;31(6):1267–76.PubMedPubMedCentral Kebede WM, Gizachew KD, Mulu GB. Prevalence and risk factors of Dyslipidemia among type 2 diabetes patients at a Referral Hospital, North Eastern Ethiopia. Ethiop J Health Sci. 2021;31(6):1267–76.PubMedPubMedCentral
20.
go back to reference Flynn ËJ, Waldo B. Gauging the treatment gap in dyslipidemia: findings from the 2009–2014 National Health and Nutrition Examination Survey. Am Heart J. 2015;150(3):1–8. Flynn ËJ, Waldo B. Gauging the treatment gap in dyslipidemia: findings from the 2009–2014 National Health and Nutrition Examination Survey. Am Heart J. 2015;150(3):1–8.
22.
go back to reference Sintayehu A, Bekele S, Tolessa D, Cheneke W. Met and associated factors among psychiatric patients in Jimma University Specialized Hospital, South West Ethiopia. Diabetes Metab Syndr Clin Res Rev. 2018;12(5):753–60.CrossRef Sintayehu A, Bekele S, Tolessa D, Cheneke W. Met and associated factors among psychiatric patients in Jimma University Specialized Hospital, South West Ethiopia. Diabetes Metab Syndr Clin Res Rev. 2018;12(5):753–60.CrossRef
23.
go back to reference Gelaye B, Girma B, Lemma S, Berhane Y. Prevalence of metabolic syndrome among working adults in Ethiopia Prevalence of metabolic syndrome among working adults in Ethiopia. Int J Hypertens. 2011;(10). Gelaye B, Girma B, Lemma S, Berhane Y. Prevalence of metabolic syndrome among working adults in Ethiopia Prevalence of metabolic syndrome among working adults in Ethiopia. Int J Hypertens. 2011;(10).
24.
go back to reference Battle DE. Diagnostic and statistical Manual of Mental Disorders (DSM) published by the american Psychiatric Association (APA)-DSM-5. Codas. 2013;25(2):190–1.CrossRef Battle DE. Diagnostic and statistical Manual of Mental Disorders (DSM) published by the american Psychiatric Association (APA)-DSM-5. Codas. 2013;25(2):190–1.CrossRef
25.
go back to reference Talbert RL. New therapeutic options in the national cholesterol Education Program Adult Treatment Panel III. Am J Manag Care. 2002;8(12 SUPPL):301–7. Talbert RL. New therapeutic options in the national cholesterol Education Program Adult Treatment Panel III. Am J Manag Care. 2002;8(12 SUPPL):301–7.
26.
go back to reference Misganaw Dr, Mariam A, Ali DH, Araya A. Epidemiology of major non-communicable diseases in Ethiopia: a systematic review. J Heal Popul Nutr. 2014;32(1):1–13. Misganaw Dr, Mariam A, Ali DH, Araya A. Epidemiology of major non-communicable diseases in Ethiopia: a systematic review. J Heal Popul Nutr. 2014;32(1):1–13.
27.
go back to reference Penninx BWJH, Lange SMM. Cardio metabolic disorders in psychiatric patients: overview, mechanisms, and implications. Dialogues Clin Neurosci. 2018;20(1):63–73.CrossRefPubMedPubMedCentral Penninx BWJH, Lange SMM. Cardio metabolic disorders in psychiatric patients: overview, mechanisms, and implications. Dialogues Clin Neurosci. 2018;20(1):63–73.CrossRefPubMedPubMedCentral
28.
go back to reference Si MW, Yang MK, Fu XD. Effect of hypothalamic-pituitary-adrenal axis alterations on glucose and lipid metabolism in diabetics. Genet Mol Res. 2015;14(3):9562–70.CrossRefPubMed Si MW, Yang MK, Fu XD. Effect of hypothalamic-pituitary-adrenal axis alterations on glucose and lipid metabolism in diabetics. Genet Mol Res. 2015;14(3):9562–70.CrossRefPubMed
29.
go back to reference Kim HJ, Kim Y, Cho Y, Jun B, Oh KW. Trends in the prevalence of major cardiovascular disease risk factors among korean adults: results from the Korea National Health and Nutrition Examination Survey, 1998–2012. Int J Cardiol. 2014;174(1):64–72.CrossRefPubMed Kim HJ, Kim Y, Cho Y, Jun B, Oh KW. Trends in the prevalence of major cardiovascular disease risk factors among korean adults: results from the Korea National Health and Nutrition Examination Survey, 1998–2012. Int J Cardiol. 2014;174(1):64–72.CrossRefPubMed
30.
go back to reference Basulaiman M, El Bcheraoui C, Tuffaha M, Robinson M, Daoud F, Jaber S, et al. Hypercholesterolemia and its associated risk factors-Kingdom of Saudi Arabia, 2013. Ann Epidemiol. 2014;24(11):801–8.CrossRefPubMed Basulaiman M, El Bcheraoui C, Tuffaha M, Robinson M, Daoud F, Jaber S, et al. Hypercholesterolemia and its associated risk factors-Kingdom of Saudi Arabia, 2013. Ann Epidemiol. 2014;24(11):801–8.CrossRefPubMed
31.
go back to reference Kifle ZD, Alehegn AA, Adugna M, Bayleyegn B. Prevalence and predictors of dyslipidemia among hypertensive patients in Lumame Primary Hospital, Amhara, Ethiopia: a cross-sectional study. Metab Open. 2021;11:100108.CrossRef Kifle ZD, Alehegn AA, Adugna M, Bayleyegn B. Prevalence and predictors of dyslipidemia among hypertensive patients in Lumame Primary Hospital, Amhara, Ethiopia: a cross-sectional study. Metab Open. 2021;11:100108.CrossRef
32.
go back to reference Kemal A, Ahmed M, Sinaga Teshome M, Abate KH. Central Obesity and Associated Factors among Adult Patients on Antiretroviral Therapy (ART) in Armed Force Comprehensive and Specialized Hospital, Addis Ababa, Ethiopia. J Obes. 2021; 2021:221–31. Kemal A, Ahmed M, Sinaga Teshome M, Abate KH. Central Obesity and Associated Factors among Adult Patients on Antiretroviral Therapy (ART) in Armed Force Comprehensive and Specialized Hospital, Addis Ababa, Ethiopia. J Obes. 2021; 2021:221–31.
33.
go back to reference Kolovou G, et al. Pathophysiology of Dyslipidemia in the metabolic syndrome. Postgrad Med journa; 2014. Kolovou G, et al. Pathophysiology of Dyslipidemia in the metabolic syndrome. Postgrad Med journa; 2014.
Metadata
Title
Magnitude and associated factors of dyslipidemia among patients with severe mental illness in dire Dawa, Ethiopia: neglected public health concern
Authors
Dilnessa Fentie
Shegaye Yibabie
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2023
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-023-03327-3

Other articles of this Issue 1/2023

BMC Cardiovascular Disorders 1/2023 Go to the issue

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

Keynote webinar | Spotlight on medication adherence

  • Webinar | 27-06-2024 | 18:00 (CEST)

Medication non-adherence is a major barrier to effective healthcare delivery; half of all patients do not follow their doctor’s recommendations or treatment plan.

Our experts explain the fundamentals with a practical discussion of how to manage non-adherence in two common scenarios: hypertension and asthma control.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Watch now